# Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

> **NCT04027023** · PHASE4 · UNKNOWN · sponsor: **Sciema UG** · enrollment: 9 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Diabetes mellitus Type 2 De-escalation treatment (DET)

## Key facts

- **NCT ID:** NCT04027023
- **Lead sponsor:** Sciema UG
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-30
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-05-31
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2021-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04027023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04027023, "Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04027023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*